CAS 202825-45-4

(S)-2-((4-((2-Fluorobenzyl)oxy)benzyl)amino)propanamide methanesulfonate

CAS: 202825-45-4

Formel: C₁₈H₂₃FN₂O₅S

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 398.4490

Ref: IN-DA0028G2

Ralfinamide mesylate

CAS: 202825-45-4

Ralfinamide mesylate

Formel: C₁₈H₂₃FN₂O₅S

Reinheit: ≥98%

Molekulargewicht: 398.45

Ref: 54-BUP07125

Ralfinamide Mesylate

CAS: 202825-45-4

Ralfinamide Mesylate

Formel: C₁₇H₁₉FN₂O₂CH₃SO₃H

Reinheit: 98%

Molekulargewicht: 398.45

Ref: 54-PC108889

Ralfinamide mesylate

CAS: 202825-45-4

Ralfinamide mesylate (FCE-26742A (mesylate)) is an orally available Na+ channel blocker.

Formel: C₁₈H₂₃FN₂O₅S

Reinheit: 99.83%

Farbe und Form: Solid

Molekulargewicht: 398.45

Ref: TM-T7547

Ralfinamide Mesylate

CAS: 202825-45-4

Applications Ralfinamide mesylate is a mixed sodium and N-type calcium channel protein inhibitor. Inhibitory activity of Ralfinamide mesylate is voltage dependent, with higher potency towards inactivated channels. Ralfinamide mesylate is useful in preventing, alleviating and curing a wide range of pathologies, including pain, migraine, peripheral diseases, cardiovascular diseases, inflammatory processes affecting all body systems, disorders affecting skin and related tissues, disorders of the respiratory system, disorders of the immune and endocrinol. systems, gastrointestinal, urogenital, metabolic and seizure disorders.
References Bayes, M., et al.: Methods. Find. Exp. Clin. Pharmacol., 27, 411 (2005); Pevarello, P., et al.: J. Med. Chem., 41, 579 (1998); Bauer, M., et al.: Pharmacol., 85, 297 (2010);

Formel: C₁₇H₁₉FN₂O₂·CH₄O₃S

Farbe und Form: Neat

Molekulargewicht: 398.449

Ref: TR-R075000

(S)-2-((4-((2-Fluorobenzyl)oxy)benzyl)amino)propanamide methanesulfonate

CAS: 202825-45-4

Formel: C₁₈H₂₃FN₂O₅S

Reinheit: ≥98%(HPLC)

Molekulargewicht: 398.45

Ref: 10-F227571